Form 4: InnovAge Holding Corp. Executive Feifer Reports Stock Transaction

Richard Feifer, Chief Medical Officer of InnovAge Holding Corp., reports disposition of shares to cover tax obligations.

Summary

• Richard Feifer, the Chief Medical Officer of InnovAge Holding Corp., filed a Form 4 on June 7, 2024, reporting a transaction that occurred on June 6, 2024.
• The transaction involved the disposition of 8,023 shares of Common Stock at a price of $4.83 per share to satisfy tax obligations related to the vesting and settlement of restricted stock units.
• Following the transaction, Feifer directly owns 235,211 shares of InnovAge Holding Corp.
• The filing indicates that the transaction was not made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine stock transaction for tax purposes. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard transaction to cover tax obligations related to equity compensation.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares to cover tax obligations.

Key Dates